-
1 Comment
Sunzen Biotech Berhad is currently in a long term uptrend where the price is trading 18.2% above its 200 day moving average.
From a valuation standpoint, the stock is 82.9% cheaper than other stocks from the Other sector with a price to sales ratio of 1.1.
Sunzen Biotech Berhad's total revenue sank by 67.2% to $20M since the same quarter in the previous year.
Its net income has increased by 90.7% to $-383K since the same quarter in the previous year.
Finally, its free cash flow fell by 1.6% to $3M since the same quarter in the previous year.
Based on the above factors, Sunzen Biotech Berhad gets an overall score of 3/5.
| Industry | Food & Tobacco |
|---|---|
| Sector | Consumer Non-Cyclicals |
| ISIN | MYQ0148OO005 |
| CurrencyCode | MYR |
| Exchange | KLSE |
| Dividend Yield | 0.0% |
|---|---|
| Beta | nan |
| Target Price | None |
| PE Ratio | None |
| Market Cap | 148M |
None
Here's how to backtest a trading strategy or backtest a portfolio for 0148.KLSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
